-+ 0.00%
-+ 0.00%
-+ 0.00%

SRX Global buys senior secured debt in CERo Therapeutics Holdings

PUBT·09/02/2026 20:48:21
Listen to the news
SRX Global buys senior secured debt in CERo Therapeutics Holdings
  • SRX Global bought senior secured debt in CERo Therapeutics Holdings to fund development of its engineered T-cell therapy program.
  • Proceeds are expected to accelerate CERo’s lead candidate, CER-1236, in the Phase 1 CERTAIN-T trial for hematologic cancers.
  • CERo has treated six patients; the latest higher-dose cohort reported no dose-limiting toxicities during the assessment period.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Global Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041250), on September 02, 2026, and is solely responsible for the information contained therein.